Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Rosario Custidiano"'
Autor:
Carolina Pavlovsky, Bianca Vasconcelos Cordoba, María Belén Sanchez, Beatriz Moiraghi, Ana Varela, Rosario Custidiano, Isolda Fernandez, Maria Josefina Freitas, Maria Verónica Ventriglia, Georgina Bendek, Romina Mariano, María José Mela Osorio, Miguel Angel Pavlovsky, Ana García de Labanca, Cecilia Foncuberta, Isabel Giere, Masiel Vera, Mariana Juni, Jose Mordoh, Julio Cesar Sanchez Avalos, Gerardo Cueto, Silvia Miranda, Estrella Mariel Levy, Michele Bianchini
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-4 (2023)
Abstract Treatment-free remission (TFR) in chronic myeloid leukemia (CML) is safe under adequate molecular monitoring, but questions remain regarding which factors may be considered predictive for TFR. Argentina Stop Trial (AST) is a multicenter TFR
Externí odkaz:
https://doaj.org/article/8fe9929083cf47d5a46398245f9bd84d
Autor:
María Belén Sanchez, Bianca Vasconcelos Cordoba, Carolina Pavlovsky, Beatriz Moiraghi, Ana Varela, Rosario Custidiano, Isolda Fernandez, María Josefina Freitas, María Verónica Ventriglia, Georgina Bendek, Romina Mariano, María José Mela Osorio, Miguel Arturo Pavlovsky, Ana García de Labanca, Cecilia Foncuberta, Isabel Giere, Masiel Vera, Mariana Juni, José Mordoh, Julio Cesar Sanchez Avalos, Estrella Mariel Levy, Michele Bianchini
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionTreatment-free remission (TFR) in patients with chronic myeloid leukemia in chronic phase is considered a safe option if suitable molecular monitoring is available. However, the question arises as to which factors can contribute to the ma
Externí odkaz:
https://doaj.org/article/c31cf40a2c9d4dd98ac2f1617ee73530
Autor:
Laura Korin, Santiago Cranco, Lucia Fuente, Adriana Vitriu, Paola Ochoa, Evelina Babuin, Olivia Gelo, Luis Ayala, Andrea Novoa, Paula Tempra, Maria Belen Venegas, Anahi Vijnovich Baron, Norma Tartas, Rosario Custidiano, Cecilia Foncuberta, Julio Sanchez Avalos
Publikováno v:
HemaSphere, Vol 6, Pp 19-19 (2022)
Externí odkaz:
https://doaj.org/article/50042d1cdd6840f2a15ad792b05ae2d2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Valeria J. Sarapura Martinez, Brenda Buonincontro, Chiara Cassarino, Juliana Bernatowiez, Ana Colado, Gregorio Cordini, Maria del Rosario Custidiano, Carolina Mahuad, Miguel A. Pavlovsky, Raimundo F. Bezares, Nicolás O. Favale, Mónica Vermeulen, Mercedes Borge, Mirta Giordano, Romina Gamberale
Publikováno v:
Frontiers in Oncology. 13
The treatment of chronic lymphocytic leukemia (CLL) patients with venetoclax-based regimens has demonstrated efficacy and a safety profile, but the emergence of resistant cells and disease progression is a current complication. Therapeutic target of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ad1c25b4b1726519b94242fcc6f654c
https://doi.org/10.3389/fonc.2023.1143881
https://doi.org/10.3389/fonc.2023.1143881
Autor:
Romina Gamberale, Gonzalo Martín Garate, Mirta Giordano, Mercedes Borge, Esteban Enrique Elías, Julio Cesar Sanchez Avalos, Raimundo F. Bezares, Valeria Judith Sarapura Martinez, Miguel A. Pavlovsky, Gregorio Cordini, Ana Colado, Horacio Fernandez Grecco, Mikele Amondarain, Maria del Rosario Custidiano
Publikováno v:
Cancer Immunology, Immunotherapy. 71:979-987
Venetoclax treatment has demonstrated efficacy and a safety profile in chronic lymphocytic leukemia (CLL) patients, however the emergence of resistant cells is a current complication. We and others, previously reported that the activation of CLL cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c29ab89565c0f3d1976346da84a59ba1
https://doi.org/10.1007/s00262-021-03043-x
https://doi.org/10.1007/s00262-021-03043-x
Autor:
Ricardo Khalil Khalil Tannuri, Beatriz Moiraghi, Miguel Arturo Pavlovsky, Ana Ines Varela, Michele Bianchini, Isabel Giere, Isolda I. Fernandez, Georgina Bendek, Romina Mariano, Josefina Freitas, Veronica Ventriglia, Maria Del Rosario Custidiano, Ana Garcia de Labanca, Julio Cesar Sanchez Avalos, Maria J. Mela Osorio, Bianca Vasconcelos Cordoba, Maria Belen Sanchez, Mariana Juni, Marcos Bianco, Carolina Pavlovsky
Publikováno v:
Blood. 140:5088-5089
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37246a6fd1a77a7673d8293071896101
https://doi.org/10.1182/blood-2022-162407
https://doi.org/10.1182/blood-2022-162407
Autor:
Marcelo, Zylberman, Fernando A, Díaz-Couselo, Célica, Irrazabal, Santiago, Flagel, Rosario, Custidiano, Agustina, Racciopi, Carla, Nicolini, Pierina, Bachetti, Juan, Rébora, Natalia, Manzano, Margarita, Tavella, Sandra, Valle, Laura, Noro, Sebastián, Halac, Eric, Cassal, Lisandro, Paganini, Marina, Aguirre, Miguel, Dictar
Publikováno v:
Medicina. 81(5)
Cancer patients are exposed to more complications from COVID-19 than non-cancer patients. We report a cohort of 74 cancer patients (87.8% with solid neoplasia and 12.2% with hematological diseases) with COVID-19 infection admitted to a tertiary medic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9b88650d4eb6dde344c593550e06543d
https://pubmed.ncbi.nlm.nih.gov/34633941
https://pubmed.ncbi.nlm.nih.gov/34633941
Autor:
Alexia Vereertbrugghen, Ana Colado, Ernesto Gargiulo, Raimundo Fernando Bezares, Horacio Fernández Grecco, Gregorio Cordini, Maria del Rosario Custidiano, Jean-Hugues François, Guy Berchem, Mercedes Borge, Jerome Paggetti, Etienne Moussay, Romina Gamberale, Mirta Giordano, Pablo Elías Morande
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
Current standard treatment of patients with hairy cell leukemia (HCL), a chronic B-cell neoplasia of low incidence that affects the elderly, is based on the administration of purine analogs such as cladribine. This chemotherapy approach shows satisfa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::333143842cc3bb6872a62c8b6af84b6d
https://doi.org/10.3389/fonc.2021.598319
https://doi.org/10.3389/fonc.2021.598319
Autor:
Maria Lucia Fuente, Santiago Cranco, J.C. Sanchez Avalos, A Vijnovich Baron, Laura Korin, Andrea Novoa, Maria Belen Venegas, Paola Ochoa, Paula Tempra, Maria Del Rosario Custidiano, Evelina Babuin, Maria Cecilia Foncuberta, F Diaz Couselo, N Tartas, Adriana Vitriu
Publikováno v:
Hematological Oncology. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a0bf729808a33f5a506c51b483570f1
https://doi.org/10.1002/hon.11_2881
https://doi.org/10.1002/hon.11_2881